| Dynamic RNAs and Structure-Guided Small Molecule Drug Discovery | |||||
|
Tue19 Oct02:00pm(30 mins)
|
|
Isaac Kimsey |
|
Yang Zheng | |
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| DNA-Encoded Library Technology for Drug Discovery | |||||
|
Tue19 Oct02:30pm(5 mins)
|
|
Assunta Romano | |||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
|
Tue19 Oct02:35pm(5 mins)
|
Exhibitor Slot |
Room: Hall 1B |
| Small activating RNAs from concept to Phase 2 clinical trial | |||||
|
Tue19 Oct02:45pm(30 mins)
|
|
Nagy Habib |
|
Vikash Reebye | |
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| X-reactivation as an approach to treating Rett Syndrome | |||||
|
Tue19 Oct04:30pm(30 mins)
|
|
Jeannie Lee | |||
| Session : Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA | |||||
| Room: Hall 1B | |||||
| High resolution anatomical mapping of gene expression using targeted in situ sequencing | |||||
|
Wed20 Oct11:00am(30 mins)
|
|
Mats Nilsson | |||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment | |||||
|
Wed20 Oct11:30am(30 mins)
|
|
Sun Yung | |||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Live cell compatible super resolution fluorescence microscopy for 3D imaging | |||||
|
Wed20 Oct12:00pm(30 mins)
|
|
Ilaria Testa |
|
Francesca Pennacchietti | |
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Single-cell CRISPR screens in primary human T cells | |||||
|
Wed20 Oct12:30pm(15 mins)
|
|
Tilmann Buerckstuemmer | |||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| R&D at the New Speed of Science: Accelerate your R&D Transformation with Benchling | |||||
|
Wed20 Oct12:45pm(5 mins)
|
|
Tali Bloom | |||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Introducing an electronic sensor to measure affinity of intermolecular interactions | |||||
|
Wed20 Oct12:50pm(5 mins)
|
|
Sylwia Mankowska | |||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| All Human Drug Research Solutions | |||||
|
Wed20 Oct12:55pm(5 mins)
|
|
Paul Gallant | |||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Chemical Materials Design | |||||
|
Wed20 Oct02:30pm(30 mins)
|
|
Ben Slater | |||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| Quantum computing: a new frontier in drug discovery? | |||||
|
Wed20 Oct03:00pm(30 mins)
|
|
Sam Genway | |||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| A structural biology community assessment of AlphaFold 2 applications | |||||
|
Wed20 Oct03:40pm(30 mins)
|
|
Pedro Beltrao | |||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
| MELLODDY: privacy-preserving federated machine learning across pharma partners | |||||
|
Wed20 Oct04:10pm(30 mins)
|
|
Hugo Ceulemans | |||
| Session : Disruptive technologies | |||||
| Room: Hall 1B | |||||
